Clinical Trial Update: Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix [NA]

View source ↗

Summary

The HEALED trial evaluating PriMatrix for diabetic foot ulcers has been terminated; this entry notes the study status without reporting final results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Ulcer

Drugs mentioned

• PriMatrix (acellular dermal matrix)

Snippet

Sponsor: Integra LifeSciences Corporation | Conditions: Foot Ulcer, Diabetic | NA | Status: TERMINATED